ArticleLeukemia2021

Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab.

Estefanía García-Guerrero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.